Brentuximab vedotin as a bridge to allogeneic stem-cell transplantation for refractory or relapsing patients with CD30 positive anaplastic or T-cell non-Hodgkin lymphomas: a study on behalf of the SFGM-TC
| Image |  |
|---|---|
| Description | scientific article published on 24 April 2019 |
| Author/s |
author: Flore Sicre de Fontbrune |
| Publication date | April 24, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |